AbbVie Humira Lawsuit Withstands Alvotech Attack

Attempt Fails To Dismiss Adalimumab Litigation Ahead Of FDA Decision On AVT02 Biosimilar

Blue Button Dismiss
Alvotech had attempted to have the litigation dismissed • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin